Relevance and Efficiency of SecOnd Line Workup for Uveitis

Launched by CENTRAL HOSPITAL, NANCY, FRANCE · Oct 22, 2023

Keywords

ClinConnect Summary

This clinical trial is studying the effectiveness of a follow-up examination, known as a "second-line workup," for patients with uveitis, an eye condition that can cause inflammation and vision problems. The goal is to determine how useful these additional tests are for understanding the underlying causes of uveitis after initial tests have been done. Researchers want to find out if these follow-up exams provide important information that can help in managing the condition better.

To participate in this trial, individuals need to be adults who have already undergone at least one initial examination for uveitis at the research center. However, those with only a simple case of uveitis that quickly responds to treatment, cases where the diagnosis is very clear, or those who do not wish to share their medical information will not be included. Although the trial is not yet recruiting participants, those who join can expect to contribute to important research that may improve care for future patients with uveitis.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • adult patient
• • at least one etiological workup in our center
• Exclusion Criteria:
• • only episode of acute anterior uveitis quickly responding to topical treatments
• • diagnostic ophthalmologically obvious
• • opposition to collection of data